Research Article
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
Figure 2
Comparison of the serum leucine-rich alpha-2 glycoprotein (LRG) levels between active and inactive disease, according to the involved area in patients with ulcerative colitis (a) and Crohn’s disease (b). The bars indicate the percentile. The lower bar indicates the 10th percentile, and the upper bar indicates the 90th percentile. I: inactive; A: active; n.s.: not significant.
(a) |
(b) |